New Biotechnology Books
Two new biotechnology books due out in March 2008: [AMAZONPRODUCT=0973467673] Best Practices in Biotechnology Education 22 International Best Practices in […]
Two new biotechnology books due out in March 2008: [AMAZONPRODUCT=0973467673] Best Practices in Biotechnology Education 22 International Best Practices in […]
On returning from a meeting with a small biotechnology firm in which I serve on the advisory board, I was
Want biotechnology venture capital? Use a shotgun! Read Post »
After months of work, the January issue of the Journal of Commercial Biotechnology, my first as managing editor, has just
Journal of Commercial Biotechnology – January 2008 Read Post »
My recent presentation at the “Biotechnology for Turkey” conference has been posted online. My central thesis was that the challenges
Guest content from John Avellanet, managing director of Cerulean Associates: The US Food and Drug Administration (FDA) intends to increase
At a recent event was recently asked about investment outcomes for venture capitalists. I didn’t have any recent data, so
I’ll be giving a talk on “Career Development in Biotechnology” next week in the AstraZeneca seminar series at the University
Bio-Rad’s got an interesting website up: RethinkPCR. The company’s name isn’t posted on the front page, but is readily available
Today marks the 25th anniversary of the FDA’s approval of the first drug produced by biotechnology, Genentech’s Humulin. I often
I’ve been waiting to write up the Exubera story for the next edition of Building Biotechnology, and the story just
Exubera: The road to hell is paved with good intentions Read Post »
Get new actionable insights and updates from BiotechBlog